Take a Survey to Help Researchers Develop a Study for “As Needed” Blood Thinners Using a Smart Watch

Update: This survey is now closed.

Researchers need your help to find new ways to prevent stroke in patients with atrial fibrillation

  • Summary:  You can help with a proposed study leveraging a smart watch and “pill-in-the-pocket” blood thinners to prevent afib-related strokes
  • Reading time:  2–3 minutes

Dr. Rod Passman, a researcher at Northwestern University who spoke at the Get in Rhythm. Stay in Rhythm.® Atrial Fibrillation Patient Conference this past weekend, needs your help.

August 12, 2021

Please take his survey that is intended to gauge afib patient interest in a proposed research study that will use a specially-designed smartwatch to monitor your atrial fibrillation and limit the time you will need to take blood thinners. 

The study would compare the experiences of those taking blood thinners continuously with those wearing a smartwatch to identify when blood thinners may be needed (as “pill-in-the-pocket”).

Please take the survey at https://www.surveymonkey.com/r/REACT-AF

The survey results are completely anonymous and will be used for planning purposes only. Your participation is greatly appreciated. Please share this with other afib patients.

Below is information from Dr. Passman about the potential study.

We need your help to find new ways to prevent stroke in patients with atrial fibrillation!

We are developing a study to identify new ways to prevent strokes in patients with atrial fibrillation and need your help.  Atrial fibrillation can increase the risk of stroke in some patients. Current treatment for these patients is life-long, continuous “blood thinners” (anticoagulation), which have been shown to reduce the risk of stroke but can cause bleeding.

We are designing a new study that could use a commercially available “smartwatch” that constantly monitors for atrial fibrillation to determine whether giving blood thinners only when needed (during and for a month after an episode of atrial fibrillation) is as effective and safer than continuous blood thinners.
To help design the study, which will be proposed to potential funders, please complete the short survey below:


This survey is being managed by StopAfib.org.